Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sensitivity analysis of the effects of non-pharmaceutical interventions on COVID-19 in Europe

View ORCID ProfileKristian Soltesz, Fredrik Gustafsson, View ORCID ProfileToomas Timpka, Joakim Jaldén, Carl Jidling, Albin Heimerson, Thomas B. Schön, Armin Spreco, Joakim Ekberg, Örjan Dahlström, Fredrik Bagge Carlson, Anna Jöud, Bo Bernhardsson
doi: https://doi.org/10.1101/2020.06.15.20131953
Kristian Soltesz
1Lund University, Department of Automatic Control, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristian Soltesz
  • For correspondence: kristian@control.lth.se
Fredrik Gustafsson
2Linköping University, Department of Electrical Engineering, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toomas Timpka
3Linköping University, Department of Health, Medicine and Caring Sciences, Sweden
4Region Östergötland, Unit for Public Health and Statistics, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Toomas Timpka
Joakim Jaldén
5KTH Royal Institute of Technology, Division of Information Science and Engineering, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Jidling
6Uppsala University, Department of Information Technology, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albin Heimerson
1Lund University, Department of Automatic Control, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas B. Schön
6Uppsala University, Department of Information Technology, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Armin Spreco
3Linköping University, Department of Health, Medicine and Caring Sciences, Sweden
4Region Östergötland, Unit for Public Health and Statistics, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joakim Ekberg
3Linköping University, Department of Health, Medicine and Caring Sciences, Sweden
4Region Östergötland, Unit for Public Health and Statistics, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Örjan Dahlström
7Linköping University, Department of Behavioural Sciences and Learning, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Bagge Carlson
8National University of Singapore, Acoustic Research Laboratory, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Jöud
9Lund University, Department of Laboratory Medicine, Sweden
10Skåne University Hospital, Department of Research and Development, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Bernhardsson
1Lund University, Department of Automatic Control, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The role of non-pharmaceutical interventions (NPIs) on the spread of SARS-CoV-2 has drawn significant attention, both scientific and political. Particularly, an article by the Imperial College COVID-19 Response Team (ICCRT), published online in Nature on June 8, 2020, evaluates the efficiency of 5 NPIs. Based on mortality data up to early May, it concludes that only one of the interventions, lockdown, has been efficient in 10 out of 11 studied European countries.

We show, via simulations using the ICCRT model code, that conclusions regarding the effectiveness of individual NPIs are not justified. Our analysis focuses on the 11th country, Sweden, an outlier in that no lockdown was effectuated. The new simulations show that estimated NPI efficiencies across all 11 countries change drastically unless the model is adapted to give the Swedish data special treatment. While stated otherwise in the Nature article, such adaptation has been done in the model code reproducing its results: An ungrounded country-specific parameter said to have been introduced in all 11 countries, is in the code only activated for Sweden. This parameter de facto provides a new NPI category, only present in Sweden, and with an impact comparable to that of a lockdown.

While the considered NPIs have unarguably contributed to reduce virus spread, our analysis reveals that their individual efficiency cannot be reliably quantified by the ICCRT model, provided mortality data up to early May.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially supported by the ELLIIT Strategic Research Area, by the Wallenberg AI, Autonomous Systems and Software Program (WASP) funded by the Knut and Alice Wallenberg Foundation, and by the Swedish Foundation for Strategic Research (SSF) via the project ASSEMBLE (contract number: RIT15-0012).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author’s contributions Study conceptualisation: Bernhardsson, Gustafsson, Jaldén, Soltesz, Timpka

  • Analysis and interpretation of model weaknesses: Bernhardsson, Bagge Carlson, Jaldén, Soltesz Code preparation and execution: Heimerson, Jidling

  • Background literature review: Bernhardsson, Jöud, Spreco,Timpka

  • Manuscript writing and reviewing: Bernhardsson, Dahlström, Ekberg, Jaldén, Jöud, Schön, Soltesz, Spreco, Timpka

  • Competing interests: None.

  • Funding statement: This work was partially supported by the ELLIIT Strategic Research Area, by the Wallenberg AI, Autonomous Systems and Software Program (WASP) funded by the Knut and Alice Wallenberg Foundation, and by the Swedish Foundation for Strategic Research (SSF) via the project ASSEMBLE (contract number: RIT15-0012).

Data Availability

We have used the original model code and associated data, provided in [9] and described as "the exact code that was used" in [4]. A fork of this code, generating the figures in this manuscript, is provided in [10].

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sensitivity analysis of the effects of non-pharmaceutical interventions on COVID-19 in Europe
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sensitivity analysis of the effects of non-pharmaceutical interventions on COVID-19 in Europe
Kristian Soltesz, Fredrik Gustafsson, Toomas Timpka, Joakim Jaldén, Carl Jidling, Albin Heimerson, Thomas B. Schön, Armin Spreco, Joakim Ekberg, Örjan Dahlström, Fredrik Bagge Carlson, Anna Jöud, Bo Bernhardsson
medRxiv 2020.06.15.20131953; doi: https://doi.org/10.1101/2020.06.15.20131953
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Sensitivity analysis of the effects of non-pharmaceutical interventions on COVID-19 in Europe
Kristian Soltesz, Fredrik Gustafsson, Toomas Timpka, Joakim Jaldén, Carl Jidling, Albin Heimerson, Thomas B. Schön, Armin Spreco, Joakim Ekberg, Örjan Dahlström, Fredrik Bagge Carlson, Anna Jöud, Bo Bernhardsson
medRxiv 2020.06.15.20131953; doi: https://doi.org/10.1101/2020.06.15.20131953

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1435)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10334)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2655)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (682)
  • Hematology (269)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1335)
  • Ophthalmology (403)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2421)
  • Public and Global Health (5032)
  • Radiology and Imaging (902)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)